medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2

<< Back Next >>

Med Cutan Iber Lat Am 2019; 47 (2)

Treatment of solar lentigines with only one session of laser application Nd: YAG Q-switched, 532 nm: a series of three cases

Cione MA, Expósito N, Sacchi A
Full text How to cite this article

Language: Spanish
References: 5
Page: 136-138
PDF size: 188.19 Kb.


Key words:

Solar lentigines, Nd: yag laser, therapy.

ABSTRACT

Solar lentigines are benign lesions that are produced by intense exposure to ultraviolet radiation and cause an aesthetic problem. With the Nd: YAG Q-switched laser, at a wavelength of 532 nm, the solar lentigo is eliminated quickly, without complications, with immediate incorporation into daily activities.


REFERENCES

  1. Ortonne JP et al. treatment of solar lentigines. J Am Acad Dermatol. 2006; 54 (5 Suppl 2): S262-S271.

  2. Kilmer SL et al. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd: YAG laser. A controlled, single-impact, dose-response, multicenter trial. Arch Dermatol. 1994; 130: 1515-1519.

  3. Li YT, Yang KC. Comparison of the frequency-doubled Q-switched Nd: YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999; 25: 202-204.

  4. Todd MM, Rallis TM, Gerwels JW et al. comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol. 2000; 136 (7): 841-846.

  5. Vachiramon V, Panmanee W, Techapichetvanich T et al. Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians. Lasers Surg Med. 2016; 48 (4): 354-359.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2019;47